Investigating and comparison the effect of Pedilact probiotic and Bilinaster in indirect bilirubin level in infants with exaggerated physiological jaundice
Phase 3
Recruiting
- Conditions
- eonatal Jaundice.Neonatal jaundice from other and unspecified causes
- Registration Number
- IRCT20240420061541N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Term neonate (GA>35w)
Birth weight > 2500g
Breast milk feeding
Indication for phototherapy and hospitalization by Bhutani chart
Exclusion Criteria
Less than 2 days old
With a pathological background such as sepsis, favism, congenital anomalies, asphyxia, congenital heart disease and intrauterine growth restriction
With a positive Coombs test
Undergoing blood transfusion or receiving IVIG
Treated with phenobarbital
In need of serum therapy
Consumption of Formula
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum bilirubin level (mg/dl). Timepoint: Daily up to 5 days. Method of measurement: Serum Bilirubin Level.
- Secondary Outcome Measures
Name Time Method Fecal count. Timepoint: Daily. Method of measurement: Enumeration.;Urination. Timepoint: Daily. Method of measurement: Enumeration.;Hospitalization time. Timepoint: Daily. Method of measurement: Enumeration.